Safety and tolerability of orally administered RPC1063, a novel S1P1 receptor modulator, in healthy adult volunteers, results of a phase 1 study

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: 242449e6a9afe827d9501ac7b3d4762ae9eac9c8
First added on: Feb 05, 2025